๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Carboplatin-based primary chemotherapy for infants and young children with CNS tumors

โœ Scribed by Maryam Fouladi; Sri Gururangan; Albert Moghrabi; Peter Phillips; Lindsey Gronewold; Dana Wallace; Robert A. Sanford; Amar Gajjar; Larry E. Kun; Richard Heideman

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
215 KB
Volume
115
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Salvage therapy after postoperative chem
Salvage therapy after postoperative chemotherapy for primary brain tumors in infants and very young children
โœ Paul G. Fisher; Michael N. Needle; Avital Cnaan; Huaqing Zhao; J. Russell Geyer; ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 106 KB ๐Ÿ‘ 3 views

A trend toward the use of prolonged postoperative chemotherapy, with radiotherapy deferred until relapse, has emerged for very young children with malignant brain tumors. This study was undertaken to determine the failure patterns among infants who receive such treatment and to evaluate their respon

Hearing loss in children with brain tumo
Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue
โœ Freilich, Ronnie J.; Kraus, Dennis H.; Budnick, Amy S.; Bayer, Lisa A.; Finlay, ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 602 KB

Carboplatin is less ototoxic than cisplatin, but ototoxicity may occur with carboplatin at higher doses. We evaluated hearing in children with brain tumors treated with conventional dose cisplatin followed by highdose carboplatin. Children under 6 years of age, newly diagnosed with brain tumors, wer

A phase II evaluation of thiotepa follow
A phase II evaluation of thiotepa followed by other multiagent chemotherapy regimens in infants and young children with malignant brain tumors
โœ Bassem I. Razzouk; Richard L. Heideman; Henry S. Friedman; Jesse J. Jenkins; Lar ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 561 KB

## Background: Chemotherapy may be used to delay the need for cranial irradiation in infants and young children with malignant central nervous system (cns) tumors. the polyfunctional alkylator thiotepa (tt) possesses significant in vitro and in vivo activity in many central nervous system tumors. b